Supplementary Figure 2 from MEK1/2 Inhibitors AS703026 and AZD6244 May Be Potential Therapies for &lt;i&gt;KRAS&lt;/i&gt; Mutated Colorectal Cancer That Is Resistant to EGFR Monoclonal Antibody Therapy